Published in Behav Brain Res on November 30, 1993
Binding of beta-amyloid to the p75 neurotrophin receptor induces apoptosis. A possible mechanism for Alzheimer's disease. J Clin Invest (1997) 1.66
Experimental and clinical evidence of neuroprotection by nerve growth factor eye drops: Implications for glaucoma. Proc Natl Acad Sci U S A (2009) 1.24
Chronic mild cerebrovascular dysfunction as a cause for Alzheimer's disease? Exp Gerontol (2010) 1.12
Meta-analysis: the efficacy of nootropic agent Cerebrolysin in the treatment of Alzheimer's disease. J Neural Transm (Vienna) (2007) 0.95
Gene therapy in Alzheimer's disease - potential for disease modification. J Cell Mol Med (2010) 0.90
Long-term delivery of nerve growth factor by encapsulated cell biodelivery in the Göttingen minipig basal forebrain. Mol Ther (2010) 0.84
From molecular to nanotechnology strategies for delivery of neurotrophins: emphasis on brain-derived neurotrophic factor (BDNF). Pharmaceutics (2013) 0.83
Alleviating effects of Bushen-Yizhi formula on ibotenic acid-induced cholinergic impairments in rat. Rejuvenation Res (2015) 0.81
Nonneurotropic adenovirus: a vector for gene transfer to the brain and gene therapy of neurological disorders. Int Rev Neurobiol (2003) 0.79
Alzheimer's disease: Targeting the Cholinergic System. Curr Neuropharmacol (2016) 0.78
The generation of NGF-secreting primary rat monocytes: a comparison of different transfer methods. J Immunol Methods (2013) 0.77
Effects of nerve growth factor and nitric oxide synthase inhibitors on amyloid precursor protein mRNA levels and protein stability. Open Biochem J (2012) 0.76
Biomimetic total synthesis of tricycloillicinone and mechanistic studies toward the rearrangement of prenyl phenyl ethers. Tetrahedron Lett (2008) 0.75
Optimism in the treatment of Alzheimer's disease. J Psychiatry Neurosci (1999) 0.75
Nerve growth factor-mediated regulation of low density lipoprotein receptor-related protein promoter activation. Cell Mol Neurobiol (2012) 0.75
Behavioral effects of neurotrophic factor supplementation in aging. Age (Omaha) (1999) 0.75
Effect of Estradiol on Neurotrophin Receptors in Basal Forebrain Cholinergic Neurons: Relevance for Alzheimer's Disease. Int J Mol Sci (2016) 0.75
Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med (2004) 16.58
Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group. Transplantation (1999) 2.81
Predictors of progression from mild cognitive impairment to Alzheimer disease. Neurology (2007) 2.72
Ubiquitin-binding protein p62 is present in neuronal and glial inclusions in human tauopathies and synucleinopathies. Neuroreport (2001) 2.41
The course of cognitive impairment in preclinical Alzheimer disease: three- and 6-year follow-up of a population-based sample. Arch Neurol (2000) 2.37
Neuronal nicotinic receptors in the human brain. Prog Neurobiol (2000) 2.31
Very old women at highest risk of dementia and Alzheimer's disease: incidence data from the Kungsholmen Project, Stockholm. Neurology (1997) 2.14
Age-related differences in white matter microstructure: region-specific patterns of diffusivity. Neuroimage (2009) 2.05
Prevalence of Alzheimer's disease and other dementias in an elderly urban population: relationship with age, sex, and education. Neurology (1991) 2.05
Tacrolimus once daily (ADVAGRAF) versus twice daily (PROGRAF) in de novo renal transplantation: a randomized phase III study. Am J Transplant (2010) 2.03
Molecular cloning and neurotrophic activities of a protein with structural similarities to nerve growth factor: developmental and topographical expression in the brain. Proc Natl Acad Sci U S A (1990) 1.94
Defective brain microtubule assembly in Alzheimer's disease. Lancet (1986) 1.89
Early accumulation of p62 in neurofibrillary tangles in Alzheimer's disease: possible role in tangle formation. Neuropathol Appl Neurobiol (2002) 1.79
Brain regions associated with episodic retrieval in normal aging and Alzheimer's disease. Neurology (1999) 1.78
Successful combined partial auxiliary liver and kidney transplantation in highly sensitized cross-match positive recipients. Am J Transplant (2007) 1.77
Long term outcome of temporal lobe epilepsy surgery: analyses of 140 consecutive patients. J Neurol Neurosurg Psychiatry (2002) 1.76
The occurrence of depressive symptoms in the preclinical phase of AD: a population-based study. Neurology (1999) 1.67
Infection after total hip replacement. With special reference to a discharge from the wound. J Bone Joint Surg Br (1983) 1.66
Differential protease, innate immunity, and NF-kappaB induction profiles during lung inflammation induced by subchronic cigarette smoke exposure in mice. Am J Physiol Lung Cell Mol Physiol (2005) 1.66
Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment. Neuroreport (2001) 1.63
Disruption of the low affinity receptor-binding site in NGF allows neuronal survival and differentiation by binding to the trk gene product. Cell (1992) 1.62
Relation of sedation and amnesia to plasma concentrations of midazolam in surgical patients. Clin Pharmacol Ther (1988) 1.62
Regional cerebral blood flow and oxygen metabolism during migraine with and without aura. Cephalalgia (1997) 1.61
High recurrence rate following aspiration of colloid cysts in the third ventricle. J Neurosurg (1993) 1.60
Treatment of brain abscess with cefotaxime and metronidazole: prospective study on 15 consecutive patients. Clin Infect Dis (1993) 1.57
Development and regional expression of beta nerve growth factor messenger RNA and protein in the rat central nervous system. Proc Natl Acad Sci U S A (1986) 1.56
Intracerebroventricular infusion of nerve growth factor in three patients with Alzheimer's disease. Dement Geriatr Cogn Disord (1998) 1.55
Occurrence of dementia in advanced age: the study design of the Kungsholmen Project. Neuroepidemiology (1992) 1.54
Ammonia, a selective agent for methane production by syntrophic acetate oxidation at mesophilic temperature. Water Sci Technol (2008) 1.52
Quantitative electroencephalography in mild cognitive impairment: longitudinal changes and possible prediction of Alzheimer's disease. Neurobiol Aging (2000) 1.49
Gender differences in episodic memory. Mem Cognit (1997) 1.47
Preclinical symptoms of major depression in very old age: a prospective longitudinal study. Am J Psychiatry (1998) 1.43
Castleman's disease of the leptomeninges--immunohistochemical findings in 2 cases. Clin Neuropathol (2002) 1.42
V-RISK-10: validation of a screen for risk of violence after discharge from acute psychiatry. Eur Psychiatry (2010) 1.42
Treatment of Alzheimer disease with tacrine: a cost-analysis model. Alzheimer Dis Assoc Disord (1997) 1.42
The anaesthetic potency of propofol in the rat is reduced by simultaneous intravenous administration of lignocaine. Eur J Anaesthesiol (1999) 1.41
Prenatal diagnosis of holoprosencephaly and ectopia cordis in a twin at 12 weeks' gestation. Ultrasound Obstet Gynecol (2003) 1.40
Nerve growth factors in the rat iris. Nature (1980) 1.39
Decreased protein level of nicotinic receptor alpha7 subunit in the frontal cortex from schizophrenic brain. Neuroreport (1999) 1.38
The influence of education on clinically diagnosed dementia incidence and mortality data from the Kungsholmen Project. Arch Neurol (2001) 1.38
The level of cerebrospinal fluid tau correlates with neurofibrillary tangles in Alzheimer's disease. Neuroreport (1997) 1.38
[More accurate diagnosis could identify patients suitable for tacrine therapy]. Lakartidningen (1996) 1.37
Vascular endothelial growth factor improves functional outcome and decreases secondary degeneration in experimental spinal cord contusion injury. Neuroscience (2003) 1.36
Expression of the beta-nerve growth factor gene in hippocampal neurons. Science (1988) 1.35
CSF biomarkers for Alzheimer disease correlate with cortical brain biopsy findings. Neurology (2012) 1.35
Sustained cholinesterase inhibition in AD patients receiving rivastigmine for 12 months. Neurology (2002) 1.30
Cellular and cordless telephones and the risk for brain tumours. Eur J Cancer Prev (2002) 1.29
MR volumetry of the entorhinal, perirhinal, and temporopolar cortices in drug-refractory temporal lobe epilepsy. AJNR Am J Neuroradiol (2001) 1.27
Contrasting cognitive trajectories of impending death and preclinical dementia in the very old. Neurology (2006) 1.26
No difference in cerebral glucose metabolism in patients with Alzheimer disease and differing apolipoprotein E genotypes. Arch Neurol (1997) 1.25
Retrograde axonal transport of glial cell line-derived neurotrophic factor in the adult nigrostriatal system suggests a trophic role in the adult. Proc Natl Acad Sci U S A (1995) 1.24
Occurrence of cognitive impairment and dementia in the community: a 9-year-long prospective study. Neurology (2008) 1.24
Nerve growth activities in rat peripheral nerve. Brain Res (1982) 1.24
High PIB retention in Alzheimer's disease is an early event with complex relationship with CSF biomarkers and functional parameters. Curr Alzheimer Res (2010) 1.23
Decreased protein levels of nicotinic receptor subunits in the hippocampus and temporal cortex of patients with Alzheimer's disease. J Neurochem (2000) 1.23
White-matter hyperintensity and neuropsychological functions in dementia and healthy aging. Arch Neurol (1992) 1.22
Tissue explants affecting extension and orientation of axons in cultured chick embryo ganglia. Exp Cell Res (1977) 1.22
Increased dopamine synthesis rate in medial prefrontal cortex and striatum in schizophrenia indicated by L-(beta-11C) DOPA and PET. Biol Psychiatry (1999) 1.21
Laminar distribution of nicotinic receptor subtypes in cortical regions in schizophrenia. J Chem Neuroanat (2001) 1.20
Developmental and regional expression of beta-nerve growth factor receptor mRNA in the chick and rat. Neuron (1988) 1.20
Simultaneous intracerebral microdialysis and positron emission tomography in the detection of ischemia in patients with subarachnoid hemorrhage. J Cereb Blood Flow Metab (1996) 1.18
Effects of multifactorial memory training in old age: generalizability across tasks and individuals. J Gerontol B Psychol Sci Soc Sci (1995) 1.17
Embryonic expression of the mRNA for the rat homologue of the fusin/CXCR-4 HIV-1 co-receptor. J Neuroimmunol (1997) 1.16
Synaptic pathology in Alzheimer's disease: relation to severity of dementia, but not to senile plaques, neurofibrillary tangles, or the ApoE4 allele. J Neural Transm (Vienna) (1996) 1.16
Cerebroretinal microangiopathy with calcifications and cysts. Neurology (2006) 1.16
Use of p62/SQSTM1 antibodies for neuropathological diagnosis. Neuropathol Appl Neurobiol (2007) 1.15
Effect of lignocaine and pH on propofol-induced pain. Br J Anaesth (1997) 1.15
Insulin-like growth factors and insulin-like growth factor binding proteins in cerebrospinal fluid and serum of patients with dementia of the Alzheimer type. J Neural Transm Park Dis Dement Sect (1993) 1.15
Cognitive correlates of mortality: evidence from a population-based sample of very old adults. Psychol Aging (1997) 1.13
Differential expression of brain-derived neurotrophic factor and neurotrophin 3 mRNA in lingual papillae and taste buds indicates roles in gustatory and somatosensory innervation. J Comp Neurol (1996) 1.13
Life satisfaction among the very old: a survey on a cognitively intact sample aged 90 years or above. Int J Aging Hum Dev (2001) 1.12
PET study of the pre- and post-synaptic dopaminergic markers for the neurodegenerative process in Huntington's disease. Brain (1997) 1.12
Personality and lifestyle in relation to dementia incidence. Neurology (2009) 1.12
Positron emission tomography studies in patients with locally advanced and/or metastatic breast cancer: a method for early therapy evaluation? J Clin Oncol (1995) 1.12
Patient-controlled analgesic therapy, Part IV: pharmacokinetics and analgesic plasma concentrations of morphine. Clin Pharmacokinet (1982) 1.11
Nerve growth factor affects 11C-nicotine binding, blood flow, EEG, and verbal episodic memory in an Alzheimer patient (case report). J Neural Transm Park Dis Dement Sect (1992) 1.11
Age-dependent decline of neprilysin in Alzheimer's disease and normal brain: inverse correlation with A beta levels. Neurobiol Aging (2006) 1.11
Spatial pattern of cerebral glucose metabolism (PET) correlates with localization of intracerebral EEG-generators in Alzheimer's disease. Clin Neurophysiol (2000) 1.11
Impairment of neocortical metabolism predicts progression in Alzheimer's disease. Dement Geriatr Cogn Disord (2000) 1.10
APOE and cognitive decline in preclinical Alzheimer disease and non-demented aging. Neurology (2004) 1.10
Lipid composition in different regions of the brain in Alzheimer's disease/senile dementia of Alzheimer's type. J Neurochem (1992) 1.09
Chimeric molecules with multiple neurotrophic activities reveal structural elements determining the specificities of NGF and BDNF. EMBO J (1991) 1.09
Brain activation in young and older adults during implicit and explicit retrieval. J Cogn Neurosci (1997) 1.09
Cellular expression of GDNF mRNA suggests multiple functions inside and outside the nervous system. Cell Tissue Res (1996) 1.08
Nerve growth factor mRNA and protein in the testis and epididymis of mouse and rat. Proc Natl Acad Sci U S A (1988) 1.08
MR imaging in cerebral gliomas. Tissue component analysis in correlation with histopathology of whole-brain specimens. Acta Radiol (1994) 1.07
Nicotinic and muscarinic subtypes in the human brain: changes with aging and dementia. J Neurosci Res (1992) 1.07
Blood-brain barrier in Alzheimer dementia and in non-demented elderly. An immunocytochemical study. Acta Neuropathol (1987) 1.07